All In Biotech

Free tool

FAERS Monitor: Sinuva

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209310 or its brand name (Sinuva, Mometasone Furoate). Reports on generic versions are filed under their own applications.

Reports

10,454

Serious

7,256

69% of reports

Hospitalization

3,151

Death reported

489

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,001
  • drug ineffective925
  • headache916
  • asthma904
  • off label use780
  • cough750
  • fatigue677
  • pruritus640
  • gastrooesophageal reflux disease593
  • nausea563
  • wheezing562
  • hypersensitivity556
  • pain539
  • pneumonia512
  • rash453

Reports by year received

View as table
YearReports
200457
200556
200656
200791
2008150
2009122
2010145
2011143
2012145
201396
2014108
2015168
2016299
2017326
2018764
2019769
2020734
2021982
20221,219
20231,225
20241,019
20251,028
2026752

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,705 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal56219.217.79,635
asthmaSignal90416.215.212,857
gastrooesophageal reflux diseaseSignal59314.913.87,662
hypersensitivitySignal5566.05.62,348
coughSignal7505.45.02,708
dyspnoeaSignal1,0013.63.41,890
pruritusSignal6403.43.11,073
pneumoniaSignal5123.22.9776
headacheSignal9162.92.81,207
rashSignal4532.11.9262
off label use7801.81.7284
pain5391.81.6184
fatigue6771.81.6225
nausea5631.41.376
drug ineffective9251.41.3118

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.